Shionogi & Co., Ltd. (OTCMKTS:SGIOY) Short Interest Update

Shionogi & Co., Ltd. (OTCMKTS:SGIOY) was the recipient of a significant decrease in short interest in the month of December. As of December 31st, there was short interest totalling 139,000 shares, a decrease of 27.8% from the December 15th total of 192,400 shares. Based on an average daily volume of 586,000 shares, the days-to-cover ratio is presently 0.2 days.

Shionogi & Co., Ltd. Stock Up 1.4 %

Shares of OTCMKTS:SGIOY traded up $0.10 on Friday, hitting $7.12. The company had a trading volume of 194,338 shares, compared to its average volume of 260,526. The firm’s 50-day simple moving average is $6.97 and its two-hundred day simple moving average is $8.77. The firm has a market capitalization of $12.11 billion, a price-to-earnings ratio of 12.14, a P/E/G ratio of 4.78 and a beta of 0.21. Shionogi & Co., Ltd. has a 1 year low of $6.22 and a 1 year high of $9.11.

About Shionogi & Co., Ltd.

Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.